Norges Bank’s Standard BioTools LAB Stock Holding History

Norges Bank’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-336,022	Closed	-$2.02M	–	2168
2020 Q4	$2.02M	Hold	336,022	–	–	﹤0.01%	1954
2020 Q3	$2.5M	Sell	336,022 -310,606	-48%	-$2.14M	﹤0.01%	1945
2020 Q2	$2.59M	Hold	646,628	–	–	﹤0.01%	1937
2020 Q1	$1.64M	Hold	646,628	–	–	﹤0.01%	1941
2019 Q4	$2.25M	Hold	646,628	–	–	﹤0.01%	1973
2019 Q3	$2.99M	Hold	646,628	–	–	﹤0.01%	1965
2019 Q2	$7.97M	Buy	646,628 +308,281	+91%	+$3.93M	﹤0.01%	1862
2019 Q1	$4.5M	Buy	338,347 +74,128	+28%	+$781K	﹤0.01%	1950
2018 Q4	$2.28M	Buy	264,219 +100,000	+61%	+$779K	﹤0.01%	1995
2018 Q3	$1.23M	Hold	164,219	–	–	﹤0.01%	2068
2018 Q2	$979K	Hold	164,219	–	–	﹤0.01%	2067
2018 Q1	$959K	Hold	164,219	–	–	﹤0.01%	2065
2017 Q4	$967K	Hold	164,219	–	–	﹤0.01%	2064
2017 Q3	$828K	Hold	164,219	–	–	﹤0.01%	2077
2017 Q2	$663K	Hold	164,219	–	–	﹤0.01%	2073
2017 Q1	$934K	Hold	164,219	–	–	﹤0.01%	2071
2016 Q4	$1.2M	Hold	164,219	–	–	﹤0.01%	2018
2016 Q3	$1.26M	Hold	164,219	–	–	﹤0.01%	2018
2016 Q2	$1.48M	Hold	164,219	–	–	﹤0.01%	2028
2016 Q1	$1.32M	Hold	164,219	–	–	﹤0.01%	2034
2015 Q4	$1.77M	Hold	164,219	–	–	﹤0.01%	2047
2015 Q3	$1.33M	Hold	164,219	–	–	﹤0.01%	2080
2015 Q2	$3.97M	Hold	164,219	–	–	﹤0.01%	1939
2015 Q1	$6.91M	Buy	164,219 +12,353	+8%	+$488K	﹤0.01%	1803
2014 Q4	$5.12M	Buy	151,866 +83,180	+121%	+$2.36M	﹤0.01%	1905
2014 Q3	$1.68M	Buy	+68,686	New	+$1.93M	﹤0.01%	2135

Other funds holding LAB

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank's LAB Position: Q1 2021 in Review

Norges Bank sold out of Standard BioTools (LAB) in Q1 2021, closing a stake of 336,022 shares — an estimated $2.02M sold.

Norges Bank first reported a position in LAB in Q3 2014 and held it in 26 quarters. The position peaked at $7.97M in Q2 2019. 138 funds tracked by Wall St. Rank hold LAB as of Q1 2021.

Norges Bank reported no remaining Standard BioTools position as of Q1 2021 after selling out during the quarter.
Norges Bank sold 336,022 Standard BioTools shares in Q1 2021, an estimated $2.02M.
Norges Bank first reported a position in Standard BioTools in Q3 2014 and held it in 26 quarters.
Norges Bank's Standard BioTools position peaked at $7.97M in Q2 2019.
138 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2021.

Based on Norges Bank's 13F filing for Q1 2021, filed 7 May 2021.